{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Lofepramine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Lofepramine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Lofepramine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "lofepramine",
    "trial_2_text": "Lofepramine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Lofepramine Supplement: 60 participants will take Lofepramine 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Lofepramine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Lofepramine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.20503206551074982,
      "78": 0.1976601779460907,
      "177": 0.17045919597148895,
      "123": 0.15400642156600952,
      "17": 0.1527227908372879,
      "20": 0.13785646855831146,
      "21": 0.1291261613368988,
      "46": 0.12299847602844238,
      "37": 0.1229642853140831,
      "173": 0.12290064245462418,
      "189": 0.11767729371786118,
      "9": 0.11376785486936569,
      "14": 0.11372387409210205,
      "77": 0.11321713775396347,
      "68": 0.10844884812831879,
      "350": 0.10511894524097443,
      "49": 0.10465003550052643,
      "79": 0.10317198932170868,
      "188": 0.10274060070514679,
      "200": 0.10217148065567017,
      "67": 0.09844041615724564,
      "2": 0.09559950232505798,
      "228": 0.09180384874343872,
      "114": 0.08961889147758484,
      "193": 0.07996038347482681,
      "29": 0.0790431946516037,
      "126": 0.07580848783254623,
      "179": 0.07540907710790634,
      "64": 0.07511254400014877,
      "180": 0.07486642152070999,
      "104": 0.07364882528781891,
      "243": 0.07358292490243912,
      "5": 0.07161571830511093,
      "72": 0.07133562862873077,
      "85": 0.0697643905878067,
      "239": 0.06961340457201004,
      "27": 0.06915825605392456,
      "76": 0.06770727783441544,
      "101": 0.06732255220413208,
      "194": 0.06451835483312607,
      "86": 0.061137180775403976,
      "28": 0.060307130217552185,
      "61": 0.05711966007947922,
      "144": 0.056730762124061584,
      "102": 0.05518650263547897,
      "151": 0.0533718504011631,
      "122": 0.053207263350486755,
      "147": 0.052192628383636475,
      "116": 0.05200524255633354,
      "1": 0.05002414062619209,
      "18": 0.049566563218832016,
      "355": 0.04923252761363983,
      "253": 0.04911964014172554,
      "261": 0.04905494675040245,
      "139": 0.04806923866271973,
      "30": 0.04799715429544449,
      "282": 0.04779316112399101,
      "35": 0.04766068235039711,
      "69": 0.047617219388484955,
      "82": 0.046927180141210556,
      "396": 0.04636029154062271,
      "249": 0.046041399240493774,
      "131": 0.0459170937538147,
      "276": 0.04563736915588379,
      "164": 0.04553458094596863,
      "38": 0.0443783700466156,
      "191": 0.04431669041514397,
      "100": 0.04424665495753288,
      "269": 0.04410019889473915,
      "96": 0.043001409620046616,
      "262": 0.04167572036385536,
      "288": 0.0416313111782074,
      "130": 0.0413009338080883,
      "186": 0.040770601481199265,
      "234": 0.04029388725757599,
      "466": 0.03995347395539284,
      "154": 0.03882667049765587,
      "92": 0.03859148547053337,
      "142": 0.038081299513578415,
      "508": 0.03794122859835625,
      "132": 0.03753267601132393,
      "341": 0.03733125701546669,
      "256": 0.03614293038845062,
      "204": 0.03604044020175934,
      "212": 0.0353102870285511,
      "153": 0.035196226090192795,
      "286": 0.03490426763892174,
      "75": 0.034753620624542236,
      "97": 0.03460318595170975,
      "221": 0.03415631502866745,
      "441": 0.03388405218720436,
      "121": 0.03333115577697754,
      "339": 0.03207668662071228,
      "33": 0.031744226813316345,
      "454": 0.03171404078602791,
      "211": 0.0315341092646122,
      "382": 0.03120388276875019,
      "163": 0.031167516484856606,
      "400": 0.030719220638275146,
      "371": 0.030711885541677475
    },
    "trial_2_ae": {
      "87": 0.20503206551074982,
      "78": 0.1976601779460907,
      "177": 0.17045919597148895,
      "123": 0.15400642156600952,
      "17": 0.1527227908372879,
      "20": 0.13785646855831146,
      "21": 0.1291261613368988,
      "46": 0.12299847602844238,
      "37": 0.1229642853140831,
      "173": 0.12290064245462418,
      "189": 0.11767729371786118,
      "9": 0.11376785486936569,
      "14": 0.11372387409210205,
      "77": 0.11321713775396347,
      "68": 0.10844884812831879,
      "350": 0.10511894524097443,
      "49": 0.10465003550052643,
      "79": 0.10317198932170868,
      "188": 0.10274060070514679,
      "200": 0.10217148065567017,
      "67": 0.09844041615724564,
      "2": 0.09559950232505798,
      "228": 0.09180384874343872,
      "114": 0.08961889147758484,
      "193": 0.07996038347482681,
      "29": 0.0790431946516037,
      "126": 0.07580848783254623,
      "179": 0.07540907710790634,
      "64": 0.07511254400014877,
      "180": 0.07486642152070999,
      "104": 0.07364882528781891,
      "243": 0.07358292490243912,
      "5": 0.07161571830511093,
      "72": 0.07133562862873077,
      "85": 0.0697643905878067,
      "239": 0.06961340457201004,
      "27": 0.06915825605392456,
      "76": 0.06770727783441544,
      "101": 0.06732255220413208,
      "194": 0.06451835483312607,
      "86": 0.061137180775403976,
      "28": 0.060307130217552185,
      "61": 0.05711966007947922,
      "144": 0.056730762124061584,
      "102": 0.05518650263547897,
      "151": 0.0533718504011631,
      "122": 0.053207263350486755,
      "147": 0.052192628383636475,
      "116": 0.05200524255633354,
      "1": 0.05002414062619209,
      "18": 0.049566563218832016,
      "355": 0.04923252761363983,
      "253": 0.04911964014172554,
      "261": 0.04905494675040245,
      "139": 0.04806923866271973,
      "30": 0.04799715429544449,
      "282": 0.04779316112399101,
      "35": 0.04766068235039711,
      "69": 0.047617219388484955,
      "82": 0.046927180141210556,
      "396": 0.04636029154062271,
      "249": 0.046041399240493774,
      "131": 0.0459170937538147,
      "276": 0.04563736915588379,
      "164": 0.04553458094596863,
      "38": 0.0443783700466156,
      "191": 0.04431669041514397,
      "100": 0.04424665495753288,
      "269": 0.04410019889473915,
      "96": 0.043001409620046616,
      "262": 0.04167572036385536,
      "288": 0.0416313111782074,
      "130": 0.0413009338080883,
      "186": 0.040770601481199265,
      "234": 0.04029388725757599,
      "466": 0.03995347395539284,
      "154": 0.03882667049765587,
      "92": 0.03859148547053337,
      "142": 0.038081299513578415,
      "508": 0.03794122859835625,
      "132": 0.03753267601132393,
      "341": 0.03733125701546669,
      "256": 0.03614293038845062,
      "204": 0.03604044020175934,
      "212": 0.0353102870285511,
      "153": 0.035196226090192795,
      "286": 0.03490426763892174,
      "75": 0.034753620624542236,
      "97": 0.03460318595170975,
      "221": 0.03415631502866745,
      "441": 0.03388405218720436,
      "121": 0.03333115577697754,
      "339": 0.03207668662071228,
      "33": 0.031744226813316345,
      "454": 0.03171404078602791,
      "211": 0.0315341092646122,
      "382": 0.03120388276875019,
      "163": 0.031167516484856606,
      "400": 0.030719220638275146,
      "371": 0.030711885541677475
    }
  },
  "safety": {
    "trial_1_safety": 0.35561826825141907,
    "trial_2_safety": 0.35561826825141907
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4791649281978607
  }
}